Zahoor A, Khazer R, Mehraj I, Gani U, Fayaz F, Khanday F
Funct Integr Genomics. 2025; 25(1):50.
PMID: 40024973
DOI: 10.1007/s10142-025-01552-x.
He R, Liu Y, Fu W, He X, Liu S, Xiao D
Mol Cancer. 2024; 23(1):267.
PMID: 39614268
PMC: 11606237.
DOI: 10.1186/s12943-024-02172-y.
Hanggi K, Li J, Gangadharan A, Liu X, Celias D, Osunmakinde O
Cancer Cell. 2024; 42(12):2015-2031.e11.
PMID: 39577420
PMC: 11631672.
DOI: 10.1016/j.ccell.2024.10.014.
Qian J, Zhao L, Xu L, Zhao J, Tang Y, Yu M
Int J Mol Sci. 2024; 25(17).
PMID: 39273650
PMC: 11395276.
DOI: 10.3390/ijms25179703.
Xu F, Ye Y, Gao Y, Xu S
J Cancer. 2024; 15(16):5288-5307.
PMID: 39247606
PMC: 11375541.
DOI: 10.7150/jca.98738.
Targeting necroptosis: a promising avenue for respiratory disease treatment.
Cao X, Tan J, Zheng R, Wang F, Zhou L, Yi J
Cell Commun Signal. 2024; 22(1):418.
PMID: 39192326
PMC: 11350980.
DOI: 10.1186/s12964-024-01804-6.
Identification and Validation of a Necroptosis-Related Prognostic Model in Tumor Recurrence and Tumor Immune Microenvironment in Breast Cancer Management.
Wang X, Chen Z, Tang J, Cao J
J Inflamm Res. 2024; 17:5057-5076.
PMID: 39081870
PMC: 11288355.
DOI: 10.2147/JIR.S460551.
Silibinin Induces Both Apoptosis and Necroptosis with Potential Anti-tumor Efficacy in Lung Cancer.
Zhang G, Wang L, Zhao L, Yang F, Lu C, Yan J
Anticancer Agents Med Chem. 2024; 24(18):1327-1338.
PMID: 39069713
DOI: 10.2174/0118715206295371240724092314.
Proteomic Stratification of Prognosis and Treatment Options for Small Cell Lung Cancer.
Huo Z, Duan Y, Zhan D, Xu X, Zheng N, Cai J
Genomics Proteomics Bioinformatics. 2024; 22(2).
PMID: 38961535
PMC: 11423856.
DOI: 10.1093/gpbjnl/qzae033.
cGAS-ISG15-RAGE axis reprogram necroptotic microenvironment and promote lymphatic metastasis in head and neck cancer.
Li J, Tan J, Wang T, Yu S, Guo G, Li K
Exp Hematol Oncol. 2024; 13(1):63.
PMID: 38926796
PMC: 11200990.
DOI: 10.1186/s40164-024-00531-5.
Development of Biochemical and Cellular Probes to Study RIPK1 Target Engagement.
Yu X, Lin H, Li F, Wang J, Lu D
ACS Med Chem Lett. 2024; 15(6):906-916.
PMID: 38894934
PMC: 11181498.
DOI: 10.1021/acsmedchemlett.4c00104.
Single‑cell RNA‑seq necroptosis‑related genes predict the prognosis of breast cancer and affect the differentiation of CD4 T cells in tumor immune microenvironment.
Guo L, Ma X, Li H, Yan S, Zhang K, Li J
Mol Clin Oncol. 2024; 21(1):49.
PMID: 38872949
PMC: 11170320.
DOI: 10.3892/mco.2024.2747.
RIPK3 signaling and its role in regulated cell death and diseases.
Zhou Y, Xiang Y, Liu S, Li C, Dong J, Kong X
Cell Death Discov. 2024; 10(1):200.
PMID: 38684668
PMC: 11059363.
DOI: 10.1038/s41420-024-01957-w.
Pervasive loss of regulated necrotic cell death genes in elephants, hyraxes, and sea cows ().
Birkemeier M, Swindle A, Bowman J, Lynch V
bioRxiv. 2024; .
PMID: 38617256
PMC: 11014510.
DOI: 10.1101/2024.04.04.588129.
The necroptosis-related signature and tumor microenvironment immune characteristics associated with clinical prognosis and drug sensitivity analysis in stomach adenocarcinoma.
Yang B, Wang Y, Liu T, Zhang M, Luo T
Aging (Albany NY). 2024; 16(7):6098-6117.
PMID: 38546403
PMC: 11042952.
DOI: 10.18632/aging.205690.
Necroptosis and Its Involvement in Various Diseases.
Nakano H
Adv Exp Med Biol. 2024; 1444:129-143.
PMID: 38467977
DOI: 10.1007/978-981-99-9781-7_9.
Biomaterial-Based Responsive Nanomedicines for Targeting Solid Tumor Microenvironments.
Avgoustakis K, Angelopoulou A
Pharmaceutics. 2024; 16(2).
PMID: 38399240
PMC: 10892652.
DOI: 10.3390/pharmaceutics16020179.
Looking through the imaging perspective: the importance of imaging necrosis in glioma diagnosis and prognostic prediction - single centre experience.
Ma H, Zeng S, Xie D, Zeng W, Huang Y, Mazu L
Radiol Oncol. 2024; 58(1):23-32.
PMID: 38378035
PMC: 10878771.
DOI: 10.2478/raon-2024-0014.
Identification and validation of prognostic and tumor microenvironment characteristics of necroptosis index and BIRC3 in clear cell renal cell carcinoma.
Wei K, Zhang X, Yang D
PeerJ. 2023; 11:e16643.
PMID: 38130918
PMC: 10734432.
DOI: 10.7717/peerj.16643.
PANoptosis: a potential new target for programmed cell death in breast cancer treatment and prognosis.
Liu X, Miao M, Sun J, Wu J, Qin X
Apoptosis. 2023; 29(3-4):277-288.
PMID: 38001342
PMC: 10873433.
DOI: 10.1007/s10495-023-01904-7.